John W. Beck

John W. Beck discloses dealings in 2 companies, chiefly Metabasis Therapeutics Inc and Intrabiotics Pharmaceuticals Inc /DE. The record holds 42 filings, for trades running from 1 March 2006 to 19 June 2012.

On the market, this insider has only sold: 26 sales, €1.4M in total. Besides market trades, the filings include 4 share grants and 11 option exercises. In 2012 alone, the filings show no purchases and 1 sale.

On 20 June 2012 came the latest disclosure, a transaction for €111k in Intrabiotics Pharmaceuticals Inc /DE. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.